Article
A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
1 Feb 2023
Abstract excerpt
Background: Cuproptosis, a recently discovered type of programmed cell death (PCD), paves a new avenue for cancer treatment. It has been revealed that PCD-related lncRNAs play a critical role in various biological processes of lung adenocarcinoma (LUAD). However, the role of cuproptosis-related lncRNA (CuRLs) remains unclear. This study aimed to identify and validate a CuRLs-based signature for the prognostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
